Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
29.77
-0.35 (-1.16%)
Mar 31, 2025, 10:15 AM EDT - Market open

Veracyte Statistics

Total Valuation

Veracyte has a market cap or net worth of $2.32 billion. The enterprise value is $2.11 billion.

Market Cap 2.32B
Enterprise Value 2.11B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

Veracyte has 77.94 million shares outstanding. The number of shares has increased by 7.60% in one year.

Current Share Class 77.94M
Shares Outstanding 77.94M
Shares Change (YoY) +7.60%
Shares Change (QoQ) +1.84%
Owned by Insiders (%) 0.49%
Owned by Institutions (%) 103.71%
Float 77.57M

Valuation Ratios

The trailing PE ratio is 97.16 and the forward PE ratio is 25.35. Veracyte's PEG ratio is 1.01.

PE Ratio 97.16
Forward PE 25.35
PS Ratio 5.17
Forward PS 4.72
PB Ratio 1.99
P/TBV Ratio 7.16
P/FCF Ratio 36.79
P/OCF Ratio 31.26
PEG Ratio 1.01
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.98, with an EV/FCF ratio of 33.05.

EV / Earnings 87.37
EV / Sales 4.73
EV / EBITDA 41.98
EV / EBIT 78.76
EV / FCF 33.05

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.04.

Current Ratio 4.73
Quick Ratio 4.33
Debt / Equity 0.04
Debt / EBITDA 0.84
Debt / FCF 0.80
Interest Coverage 13,388.50

Financial Efficiency

Return on equity (ROE) is 2.17% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE) 2.17%
Return on Assets (ROA) 1.39%
Return on Invested Capital (ROIC) 1.47%
Return on Capital Employed (ROCE) 2.19%
Revenue Per Employee $540,976
Profits Per Employee $29,294
Employee Count 824
Asset Turnover 0.37
Inventory Turnover 7.18

Taxes

In the past 12 months, Veracyte has paid $1.61 million in taxes.

Income Tax 1.61M
Effective Tax Rate 6.24%

Stock Price Statistics

The stock price has increased by +38.67% in the last 52 weeks. The beta is 1.80, so Veracyte's price volatility has been higher than the market average.

Beta (5Y) 1.80
52-Week Price Change +38.67%
50-Day Moving Average 37.56
200-Day Moving Average 33.83
Relative Strength Index (RSI) 35.29
Average Volume (20 Days) 986,109

Short Selling Information

The latest short interest is 3.30 million, so 4.24% of the outstanding shares have been sold short.

Short Interest 3.30M
Short Previous Month 3.39M
Short % of Shares Out 4.24%
Short % of Float 4.26%
Short Ratio (days to cover) 2.88

Income Statement

In the last 12 months, Veracyte had revenue of $445.76 million and earned $24.14 million in profits. Earnings per share was $0.31.

Revenue 445.76M
Gross Profit 309.70M
Operating Income 26.78M
Pretax Income -54.79M
Net Income 24.14M
EBITDA 50.24M
EBIT 26.78M
Earnings Per Share (EPS) $0.31
Full Income Statement

Balance Sheet

The company has $289.44 million in cash and $50.74 million in debt, giving a net cash position of $238.70 million or $3.06 per share.

Cash & Cash Equivalents 289.44M
Total Debt 50.74M
Net Cash 238.70M
Net Cash Per Share $3.06
Equity (Book Value) 1.18B
Book Value Per Share 15.12
Working Capital 293.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $75.10 million and capital expenditures -$11.29 million, giving a free cash flow of $63.81 million.

Operating Cash Flow 75.10M
Capital Expenditures -11.29M
Free Cash Flow 63.81M
FCF Per Share $0.82
Full Cash Flow Statement

Margins

Gross margin is 69.48%, with operating and profit margins of 6.01% and 5.41%.

Gross Margin 69.48%
Operating Margin 6.01%
Pretax Margin 5.78%
Profit Margin 5.41%
EBITDA Margin 11.27%
EBIT Margin 6.01%
FCF Margin 14.31%

Dividends & Yields

Veracyte does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.60%
Shareholder Yield -7.60%
Earnings Yield 1.03%
FCF Yield 2.72%
Dividend Details

Analyst Forecast

The average price target for Veracyte is $42.67, which is 43.33% higher than the current price. The consensus rating is "Buy".

Price Target $42.67
Price Target Difference 43.33%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 9.00%
EPS Growth Forecast (5Y) 47.82%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Veracyte has an Altman Z-Score of 10.48 and a Piotroski F-Score of 7.

Altman Z-Score 10.48
Piotroski F-Score 7